JP2022003062A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022003062A5 JP2022003062A5 JP2021155292A JP2021155292A JP2022003062A5 JP 2022003062 A5 JP2022003062 A5 JP 2022003062A5 JP 2021155292 A JP2021155292 A JP 2021155292A JP 2021155292 A JP2021155292 A JP 2021155292A JP 2022003062 A5 JP2022003062 A5 JP 2022003062A5
- Authority
- JP
- Japan
- Prior art keywords
- temperature
- levels
- crystals
- cooled
- reslurrying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021155292A JP7642506B2 (ja) | 2016-09-06 | 2021-09-24 | （ｒ）－２－アミノ－３－フェニルプロピルカルバメートの溶媒和物フォーム |
| JP2024161956A JP2024178291A (ja) | 2016-09-06 | 2024-09-19 | （ｒ）－２－アミノ－３－フェニルプロピルカルバメートの溶媒和物フォーム |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662383822P | 2016-09-06 | 2016-09-06 | |
| JP2019512895A JP7219213B2 (ja) | 2016-09-06 | 2017-09-06 | （ｒ）－２－アミノ－３－フェニルプロピルカルバメートの溶媒和物フォーム |
| JP2021155292A JP7642506B2 (ja) | 2016-09-06 | 2021-09-24 | （ｒ）－２－アミノ－３－フェニルプロピルカルバメートの溶媒和物フォーム |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019512895A Division JP7219213B2 (ja) | 2016-09-06 | 2017-09-06 | （ｒ）－２－アミノ－３－フェニルプロピルカルバメートの溶媒和物フォーム |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024161956A Division JP2024178291A (ja) | 2016-09-06 | 2024-09-19 | （ｒ）－２－アミノ－３－フェニルプロピルカルバメートの溶媒和物フォーム |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022003062A JP2022003062A (ja) | 2022-01-11 |
| JP2022003062A5 true JP2022003062A5 (https=) | 2023-04-14 |
| JP7642506B2 JP7642506B2 (ja) | 2025-03-10 |
Family
ID=61562003
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019512895A Active JP7219213B2 (ja) | 2016-09-06 | 2017-09-06 | （ｒ）－２－アミノ－３－フェニルプロピルカルバメートの溶媒和物フォーム |
| JP2021155292A Active JP7642506B2 (ja) | 2016-09-06 | 2021-09-24 | （ｒ）－２－アミノ－３－フェニルプロピルカルバメートの溶媒和物フォーム |
| JP2024161956A Pending JP2024178291A (ja) | 2016-09-06 | 2024-09-19 | （ｒ）－２－アミノ－３－フェニルプロピルカルバメートの溶媒和物フォーム |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019512895A Active JP7219213B2 (ja) | 2016-09-06 | 2017-09-06 | （ｒ）－２－アミノ－３－フェニルプロピルカルバメートの溶媒和物フォーム |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024161956A Pending JP2024178291A (ja) | 2016-09-06 | 2024-09-19 | （ｒ）－２－アミノ－３－フェニルプロピルカルバメートの溶媒和物フォーム |
Country Status (13)
| Country | Link |
|---|---|
| US (4) | US10829443B2 (https=) |
| EP (2) | EP4364794A3 (https=) |
| JP (3) | JP7219213B2 (https=) |
| KR (1) | KR102513800B1 (https=) |
| CN (4) | CN109996540A (https=) |
| CA (1) | CA3036071A1 (https=) |
| DK (1) | DK3509582T3 (https=) |
| ES (1) | ES2970887T3 (https=) |
| FI (1) | FI3509582T3 (https=) |
| MY (1) | MY197630A (https=) |
| PH (1) | PH12019500493A1 (https=) |
| SG (1) | SG11201901998WA (https=) |
| WO (1) | WO2018048871A1 (https=) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11602512B1 (en) | 2016-07-22 | 2023-03-14 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| US12186296B1 (en) | 2016-07-22 | 2025-01-07 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| US11504347B1 (en) | 2016-07-22 | 2022-11-22 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| US12478604B1 (en) | 2016-07-22 | 2025-11-25 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| UY37341A (es) | 2016-07-22 | 2017-11-30 | Flamel Ireland Ltd | Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada |
| US11602513B1 (en) | 2016-07-22 | 2023-03-14 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| US11986451B1 (en) | 2016-07-22 | 2024-05-21 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| ES2970887T3 (es) | 2016-09-06 | 2024-05-31 | Axsome Malta Ltd | Forma de solvato de carbamato de (R)-2-amino-3-fenilpropilo |
| EP3837239A4 (en) | 2018-08-14 | 2022-05-18 | Glenmark Life Sciences Limited | PROCESS FOR THE PREPARATION OF SOLRIAMFETOL AND SALT THEREOF |
| EP3930702A1 (en) | 2019-03-01 | 2022-01-05 | Flamel Ireland Limited | Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state |
| WO2021001457A1 (en) | 2019-07-04 | 2021-01-07 | Sandoz Ag | Crystalline (r)-2-amino-3-phenylpropylcarbamate acid addition salts |
| IT202000013855A1 (it) | 2020-06-10 | 2021-12-10 | Flamma Spa | Un processo per la purificazione del (r)-2-ammino-3-fenilpropil carbammato |
| US11583510B1 (en) | 2022-02-07 | 2023-02-21 | Flamel Ireland Limited | Methods of administering gamma hydroxybutyrate formulations after a high-fat meal |
| US11779557B1 (en) | 2022-02-07 | 2023-10-10 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| AU2023375326A1 (en) * | 2022-11-07 | 2025-05-22 | Axsome Therapeutics | Compositions and methods for treating insomnia |
| CN120641090A (zh) * | 2022-12-30 | 2025-09-12 | 阿克苏姆马耳他有限公司 | 向哺乳期女性施用索安非托的方法 |
| WO2024194718A1 (en) | 2023-03-22 | 2024-09-26 | Unichem Laboratories Limited | A stable pharmaceutical composition and process for preparing thereof |
| EP4719375A1 (en) | 2023-05-30 | 2026-04-08 | Axsome Therapeutics, Inc. | Solriamfetol for treating cognitive impairment in a subject with impaired cognition associated with obstructive sleep apnea and excessive daytime sleepiness |
| KR20260033050A (ko) | 2023-06-29 | 2026-03-10 | 액섬 테라퓨틱스, 인크. | 수유 여성에게 솔리암페톨을 투여하는 방법 |
| WO2025042959A1 (en) | 2023-08-21 | 2025-02-27 | Axsome Therapeutics, Inc. | Use of solriamfetol for the treatment of orphan diseases |
| WO2025165760A1 (en) * | 2024-01-29 | 2025-08-07 | Axsome Therapeutics, Inc. | Phenylalkylamino carbamates for use in the treatment of attention deficit/hyperactivity disorder |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100197892B1 (ko) | 1994-09-09 | 1999-06-15 | 남창우 | 신규한 페닐알킬아미노 카바메이트 화합물과 그의 제조방법 |
| US5756817C1 (en) | 1995-02-11 | 2001-04-17 | Sk Corp | O-carbamoyl-phenylananinol compounds their pharmaceutically useful salts and process for preparing the same |
| KR0173862B1 (ko) | 1995-02-11 | 1999-04-01 | 조규향 | O-카바모일-(d)-페닐알라닌올 화합물과 그의 약제학적으로 유용한 염 및 이들의 제조방법 |
| KR0173863B1 (ko) | 1995-04-10 | 1999-04-01 | 조규향 | 페닐에 치환체가 있는 o-카바모일-페닐알라닌올 화합물과 그의 약제학적으로 유용한 염 및 이들의 제조방법 |
| CA2355293C (en) | 1998-12-23 | 2005-08-16 | Orphan Medical, Inc. | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
| RU2202607C2 (ru) | 2000-03-03 | 2003-04-20 | Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" | Штамм бактерий methylophilus methylotrophus - продуцент l-фенилаланина (варианты), способ получения l-фенилаланина |
| US20050080268A1 (en) * | 2003-10-08 | 2005-04-14 | Yong-Moon Choi | Process of preparing O-carbamoyl compounds in the presence of active amine group |
| CA2587481A1 (en) | 2004-10-28 | 2006-05-11 | Sk Corporation | Phenylalkylamino carbamates adjunctive therapy for depression |
| ES2435403T3 (es) * | 2005-06-08 | 2013-12-19 | Sk Biopharmaceuticals Co., Ltd. | Tratamiento de trastornos del sueño y vigilia |
| ES2344469T3 (es) | 2005-06-22 | 2010-08-27 | Sk Holdings Co., Ltd. | Tratamiento de disfuncion sexual. |
| KR102173587B1 (ko) | 2009-06-22 | 2020-11-04 | 에스케이바이오팜 주식회사 | 피로의 치료 또는 예방 방법 |
| US8232315B2 (en) | 2009-06-26 | 2012-07-31 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating drug addiction and improving addiction-related behavior |
| MX350745B (es) | 2009-11-06 | 2017-09-14 | Sk Biopharmaceuticals Co Ltd * | El uso de un compuesto de carbamoilo para el tratamiento del sindrome de fibromialgia. |
| US8895609B2 (en) | 2009-11-06 | 2014-11-25 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating attention-deficit/hyperactivity disorder |
| US8623913B2 (en) | 2010-06-30 | 2014-01-07 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating restless legs syndrome |
| US9610274B2 (en) | 2010-06-30 | 2017-04-04 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating bipolar disorder |
| US9050302B2 (en) | 2013-03-01 | 2015-06-09 | Jazz Pharmaceuticals Ireland Limited | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters |
| US9359290B2 (en) | 2013-03-13 | 2016-06-07 | Jazz Pharmaceuticals International Iii Limited | Treatment of cataplexy |
| CN110638805A (zh) | 2013-07-12 | 2020-01-03 | 爵士制药国际Iii有限公司 | 促进吸烟停止 |
| KR102309836B1 (ko) | 2013-07-18 | 2021-10-12 | 에스케이바이오팜 주식회사 | 비만의 치료 |
| TWI698415B (zh) * | 2014-02-28 | 2020-07-11 | 南韓商愛思開生物製藥股份有限公司 | 胺基羰基胺基甲酸酯化合物 |
| CN109071454B (zh) | 2016-02-16 | 2023-02-17 | 昆士兰大学 | 磺酰脲和相关化合物及其用途 |
| ES2970887T3 (es) * | 2016-09-06 | 2024-05-31 | Axsome Malta Ltd | Forma de solvato de carbamato de (R)-2-amino-3-fenilpropilo |
| KR101950254B1 (ko) | 2016-09-21 | 2019-02-20 | 유상신 | 차량탑승자의 부재를 감지하는 지능형 카시트 |
| EP3837239A4 (en) * | 2018-08-14 | 2022-05-18 | Glenmark Life Sciences Limited | PROCESS FOR THE PREPARATION OF SOLRIAMFETOL AND SALT THEREOF |
-
2017
- 2017-09-06 ES ES17849432T patent/ES2970887T3/es active Active
- 2017-09-06 CN CN201780065192.6A patent/CN109996540A/zh active Pending
- 2017-09-06 CN CN202510706413.XA patent/CN120574152A/zh active Pending
- 2017-09-06 EP EP23218015.8A patent/EP4364794A3/en active Pending
- 2017-09-06 JP JP2019512895A patent/JP7219213B2/ja active Active
- 2017-09-06 FI FIEP17849432.4T patent/FI3509582T3/fi active
- 2017-09-06 WO PCT/US2017/050233 patent/WO2018048871A1/en not_active Ceased
- 2017-09-06 EP EP17849432.4A patent/EP3509582B1/en active Active
- 2017-09-06 US US16/331,069 patent/US10829443B2/en active Active
- 2017-09-06 CN CN202511369712.5A patent/CN121202731A/zh active Pending
- 2017-09-06 SG SG11201901998WA patent/SG11201901998WA/en unknown
- 2017-09-06 DK DK17849432.4T patent/DK3509582T3/da active
- 2017-09-06 CN CN202511369602.9A patent/CN121202730A/zh active Pending
- 2017-09-06 KR KR1020197011279A patent/KR102513800B1/ko active Active
- 2017-09-06 MY MYPI2019001180A patent/MY197630A/en unknown
- 2017-09-06 CA CA3036071A patent/CA3036071A1/en not_active Abandoned
-
2019
- 2019-03-06 PH PH12019500493A patent/PH12019500493A1/en unknown
-
2020
- 2020-11-06 US US17/091,222 patent/US11560354B2/en active Active
-
2021
- 2021-09-24 JP JP2021155292A patent/JP7642506B2/ja active Active
-
2022
- 2022-12-14 US US18/066,000 patent/US12384743B2/en active Active
-
2024
- 2024-09-19 JP JP2024161956A patent/JP2024178291A/ja active Pending
-
2025
- 2025-07-11 US US19/266,767 patent/US20250340509A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022003062A5 (https=) | ||
| AU2011214423B2 (en) | Method for the preparation of rivaroxaban | |
| JP2018193405A5 (https=) | ||
| JP2018531963A5 (https=) | ||
| JP2015532645A5 (https=) | ||
| RU2593752C1 (ru) | Соединения, пригодные для синтеза бензамидных соединений | |
| JP2019529549A5 (https=) | ||
| JP2013541592A5 (https=) | ||
| JP2016121177A5 (https=) | ||
| JP2012500819A5 (https=) | ||
| JP2009179634A5 (https=) | ||
| CN106029641B (zh) | 1,1-二取代肼化合物的制造方法 | |
| CN101768150B (zh) | 2-[3-氰基-4-异丁氧基苯基]-4-甲基噻唑-5-甲酸晶型及其制备方法 | |
| JP2012233173A5 (https=) | ||
| CN103443084A (zh) | 制备苯达莫司汀的方法 | |
| AR081267A1 (es) | Procedimiento de obtencion de la forma cristalina a del febuxostat | |
| JP2016501179A5 (https=) | ||
| CN103664812B (zh) | 一种2,5-二氢-6-羟基-2-甲基-5-氧-3-巯基-1,2,4-三嗪的制备方法 | |
| CN107827886B (zh) | 一种高纯度阿维巴坦的精制制备工艺 | |
| JP2013528577A5 (https=) | ||
| CN104031068A (zh) | 一锅法制备盐酸头孢替安酯的方法 | |
| JP2019019200A5 (https=) | ||
| KR101811123B1 (ko) | 신규의 모르폴린 이인산염 및 이를 이용한 고순도 리바록사반의 제조방법 | |
| CN106432326A (zh) | L‑α‑甘油磷酰胆碱的纯化方法 | |
| CN104861025A (zh) | 醋酸乌利司他的纯化方法 |